Modi Naturals Ltd

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Modi Naturals Ltd trades at ₹400, in a confirmed uptrend and 11 weeks into that stage. That is +1.0% against its own 200-day average. It sits at 36% of a 52-week range of ₹359 to ₹471. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (6 weeks and counting).

Today the stock is in a confirmed uptrend — week 11 of stage 2, confirmed. At ₹400 it trades +1.0% versus its 200-day average and sits at 36% of its 52-week range (₹359–₹471).

Against the market, two honest reads. Cumulative: over the last 4 months the stock moved +11% while the NIFTY 500 moved +3% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (6 weeks and counting; last ahead the week of 2026-07-03) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Modi Naturals Ltd trades at 11.0× P/E, about the cheapest it has ever traded. Its long-run median P/E is 28.4×, measured across 4.2 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 11.0× is about the cheapest it has ever traded, against a long-run median of 28.4× measured over 4.2 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

One caveat before moving on: margins are the best this company has ever printed — cheap against its own history on record margins is not the same thing as cheap. If profitability mean-reverts, today's multiple is higher than it looks.

Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.

What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.

Solved at its 13 June 2026 price, Modi Naturals Ltd was paying for profit growth of about 3.4% a year. Profit itself has compounded 35.4% a year over the past 5 years. Today the market pays 11.0× P/E, the 1st percentile of its own 4-year range.

What the two numbers say together. The multiple is low against its own past, and the growth the price is paying for is below what this company has actually delivered.

How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.

Stage: Consistent Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Modi Naturals Ltd reads as consistent on its fundamental arc. Consistent — revenue and profit growth have stayed positive through the window, with ROCE at 22.0% and holding. The read is built from 10 quarters across 3 curves, on partial evidence.

Why it matters: steady curves with healthy returns are the compounding setup — the risk is the price, not the business.

One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.

4-Factor Sector Score

60.9/100 — rank 3 of 5 in Edible Oils, Agro Processing · 65% evidence confidence

Modi Naturals Ltd scores 60.9 out of 100 against the 5 companies it is compared with in Edible Oils, Agro Processing, ranking 3. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 22.1 + 17.3 + 11.5 + 10 = 60.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

Revenue Revenue is the top line: everything the company billed its customers in the period.

Modi Naturals Ltd reported ₹156 Cr of revenue in the Jun 26 quarter, +0.6% year on year. That is the 2nd straight quarter of year-on-year growth. Over 5 years it has compounded at 10.2% a year. The last full year, FY26, came in at ₹719 Cr. The last four reported quarters add to ₹720 Cr.

FY26 revenue came in at ₹719 Cr (+8.4% on the year), capping 5 years at 10.2% compound. The latest quarter (Jun 26) printed ₹156 Cr, +0.6% year on year — the 2nd consecutive quarter of year-over-year growth.

Pace check: the last four quarters averaged +6.4% growth against the decade's 10.2% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +7.3% over the last 4 quarters against +24.6%/yr over the last 8 — rolling over; TTM profit +52.9% vs +222.5%/yr — rolling over.

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Modi Naturals Ltd's operating margin is 14.0% in the Jun 26 quarter, +3.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 6 fiscal years the operating margin has ranged 1.3% to 10.0%. The current quarter is running above every full year in that window.

The latest quarter's operating margin is 14.0%, +3.0 pp against the same quarter a year ago. Across 6 fiscal years the operating margin has ranged 1.3%–10.0%, and FY26's 10.0% is the top of that band — a record year.

Why the margin moved: operating margin went +2.9 pp year on year while gross margin went +3.8 pp — the gain came mostly from the gross line: input costs and pricing.

Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Modi Naturals Ltd earned ₹12.0 Cr of net profit in the Jun 26 quarter, +20.0% year on year. It is the 6th consecutive quarter of growth. Full-year FY26 profit was ₹50.0 Cr. The 5-year compound rate is 35.4%. That is 7.7% of the quarter's revenue. The same quarter a year earlier earned ₹10.0 Cr.

Jun 26 profit was ₹12.0 Cr, +20.0% year on year — the 6th consecutive quarter of growth. On the full year, FY26 printed ₹50.0 Cr (+61.3%), and the 5-year compound rate is 35.4%.

Why profit moved: revenue contributed +0.6% and the margin +3.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.

Pace comparison, last four quarters: profit +55.0% vs revenue +6.4%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 127% of Modi Naturals Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹61.0 Cr of operating cash against ₹50.0 Cr of profit. After ₹80.0 Cr of capital spending, ₹−19.0 Cr was left as free cash.

FY26: operating cash of ₹61.0 Cr against reported profit of ₹50.0 Cr, leaving free cash of ₹−19.0 Cr after ₹80.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 127% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

Why conversion sits at 127%: the cash cycle tightened 16 days between FY21 and FY26 — cash that used to wait in the cycle now reaches the bank sooner.

Router verdict: the bigger cash user is investment — capital spending ran 6.8× depreciation over three years, so the next section's job is to check what that build-out is buying.

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Modi Naturals Ltd's cash conversion cycle runs 65 days in FY26, down from 81 days in FY21. Capital spending ran ₹135 Cr over the last 3 years. At FY26 sales of ₹719 Cr each day of that cycle holds about ₹2.0 Cr, so roughly ₹128 Cr sits inside the business at any moment.

FY26: debtors at 24 days, inventory at 64 days — roughly 2.1 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 65 days, tighter than FY21's 81.

The full loop: cash goes out to suppliers and production on day 0; stock waits 64 days to sell; customers pay about 24 days after that; and suppliers themselves are paid at 23 days — netting out to the 65-day cycle.

In money terms: at FY26 sales of ₹719 Cr, each day of the cycle holds about ₹2.0 Cr — so the 65-day loop keeps roughly ₹128 Cr sitting inside the business at any moment.

On the investment side: capital spending of ₹135 Cr over the last 3 fiscal years against ₹20.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹19.0 Cr (FY26) — capacity paid for but not yet earning.

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

Modi Naturals Ltd earns a ROCE of 22% in FY26. That is up from a trough of 2% in FY24. Return on invested capital clears the cost of that capital by +4.9 percentage points, so growth here adds value rather than only size. The wiring behind it is 7.0% net margin on 1.77× asset turns.

FY26 ROCE is 22%, recovered from a FY24 trough of 2% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY26): 7.0% net margin × 1.77× asset turns × 2.37× balance-sheet leverage ≈ 29.4% on equity. Margin does its share; leverage is a meaningful part of the equation.

The capstone test — ROIC − WACC: 16.9% − 12.0% = a +4.9 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.

Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.

Modi Naturals Ltd carries ₹161 Cr of borrowings against ₹172 Cr of equity in FY26, a debt-to-equity of 0.94. Operating profit covers the interest bill 9×. Over 5 years borrowings went from ₹21.0 Cr to ₹161 Cr. Capital spending ran ₹135 Cr across the last 3 of those years.

FY26: borrowings of ₹161 Cr against equity of ₹172 Cr — a debt-to-equity of 0.94. Operating profit covers the interest bill 9×. Over 5 years borrowings went from ₹21.0 Cr to ₹161 Cr while capital spending ran ₹135 Cr in just the last 3 — part of the build-out is riding on borrowed money.

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

No holder of Modi Naturals Ltd moved a full percentage point over the last two years — the register is quiet. Domestic institutions moved +0.0 points over the same window, to 0.0%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Promoters: +0.0 points over 8 quarters to 69.1%; Domestic institutions: +0.0 points over 8 quarters to 0.0%.

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Modi Naturals Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

Frequently asked questions